Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancer
Authors:
- Nancy NguyenNNNancy Nguyen
- Rebecca BrooksRBRebecca Brooks
- Gary LeiserowitzGLGary Leiserowitz
- Jeremy ChienJCJeremy Chien
- 1 January 2022
- journal article
- abstracts
- Published by Elsevier in Gynecologic Oncology
- Vol. 164 (1) , 3-4